WI
GNMK

WrapManager Inc’s GenMark Diagnostics, Inc GNMK Stock Holding History

WrapManager Inc’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20,546
Closed -$300K – 305
2020
Q4 		$300K Sell
20,546
-1,099
-5% -$14.6K 0.09% 202
2020
Q3 		$307K Sell
21,645
-2,348
-10% -$35.9K 0.1% 178
2020
Q2 		$353K Sell
23,993
-56,118
-70% -$570K 0.13% 165
2020
Q1 		$330K Buy
80,111
+11,948
+18% +$56K 0.15% 148
2019
Q4 		$328K Buy
68,163
+3,992
+6% +$22K 0.1% 203
2019
Q3 		$389K Buy
64,171
+884
+1% +$5.52K 0.13% 176
2019
Q2 		$411K Buy
63,287
+9,909
+19% +$69.8K 0.13% 170
2019
Q1 		$378K Sell
53,378
-4,293
-7% -$28.3K 0.12% 184
2018
Q4 		$280K Buy
57,671
+9,180
+19% +$47.8K 0.1% 207
2018
Q3 		$356K Buy
48,491
+1,676
+4% +$12.3K 0.11% 205
2018
Q2 		$299K Buy
46,815
+140
+0.3% +$925 0.1% 226
2018
Q1 		$254K Buy
46,675
+7,128
+18% +$35.4K 0.08% 227
2017
Q4 		$165K Buy
39,547
+21,679
+121% +$130K 0.05% 243
2017
Q3 		$172K Buy
+17,868
New +$186K 0.06% 238

Other funds holding GNMK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WrapManager Inc's GNMK Position: Q1 2021 in Review

WrapManager Inc sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 20,546 shares — an estimated $300K sold.

WrapManager Inc first reported a position in GNMK in Q3 2017 and held it in 14 quarters. The position peaked at $411K in Q2 2019. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

  • WrapManager Inc reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
  • WrapManager Inc sold 20,546 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $300K.
  • WrapManager Inc first reported a position in GenMark Diagnostics, Inc in Q3 2017 and held it in 14 quarters.
  • WrapManager Inc's GenMark Diagnostics, Inc position peaked at $411K in Q2 2019.
  • 164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on WrapManager Inc's 13F filing for Q1 2021, filed 10 May 2021.